1. Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study. Issue 2 (1st February 2016) Authors: Odutola, A; Ota, MO; Ogundare, EO; Antonio, M; Owiafe, P; Worwui, A; Greenwood, B; Alderson, M; Traskine, M; Verlant, V; Dobbelaere, K; Borys, D Journal: Human vaccines & immunotherapeutics Issue: Volume 12:Issue 2(2016) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗